Subtopic Deep Dive
GPX4 Regulation in Ferroptosis
Research Guide
What is GPX4 Regulation in Ferroptosis?
GPX4 regulation in ferroptosis refers to the enzymatic activity of glutathione peroxidase 4 (GPX4) that reduces lipid hydroperoxides, with its inhibition by RSL3 or loss triggering ferroptosis susceptibility controlled by post-translational modifications and parallel pathways.
GPX4 acts as the central suppressor of ferroptosis by detoxifying phospholipid hydroperoxides using glutathione. Inhibitors like RSL3 directly target GPX4 to induce ferroptosis. Parallel regulators such as FSP1 and NRF2 provide glutathione-independent protection, as shown in over 30,000 cited papers on ferroptosis mechanisms.
Why It Matters
GPX4 inhibition sensitizes cancer cells to ferroptosis, offering therapeutic potential in tumors resistant to apoptosis (Tang et al., 2020; Koppula et al., 2020). NRF2-driven GPX4 upregulation promotes cancer cell survival under oxidative stress, linking it to poor prognosis (Dodson et al., 2019; Sun et al., 2015). FSP1 acts parallel to GPX4, suggesting combination therapies targeting both pathways (Bersuker et al., 2019; Doll et al., 2019).
Key Research Challenges
Identifying novel GPX4 regulators
CRISPR screens reveal new post-translational modifiers, but validating ferroptosis specificity remains difficult amid parallel pathways like FSP1. Screens often miss context-dependent regulators in cancer (Bersuker et al., 2019). Over 3,000 citations highlight gaps in systemic identification.
Overcoming NRF2-mediated resistance
NRF2 upregulates GPX4 and antioxidant genes, conferring ferroptosis resistance in hepatocellular carcinoma (Sun et al., 2015). Inhibiting this axis without toxicity challenges therapy design (Dodson et al., 2019). Lipid peroxidation dynamics complicate targeted interventions.
Distinguishing parallel suppressors
FSP1 and AIFM2 inhibit ferroptosis independently of GPX4 via CoQ reduction, blurring therapeutic targeting (Doll et al., 2019; Bersuker et al., 2019). Quantifying contributions in vivo remains unresolved, with models showing incomplete rescue upon GPX4 knockout.
Essential Papers
Ferroptosis: past, present and future
Jie Li, Feng Cao, He-liang Yin et al. · 2020 · Cell Death and Disease · 3.8K citations
Ferroptosis: molecular mechanisms and health implications
Daolin Tang, Xin Chen, Rui Kang et al. · 2020 · Cell Research · 3.7K citations
Abstract Cell death can be executed through different subroutines. Since the description of ferroptosis as an iron-dependent form of non-apoptotic cell death in 2012, there has been mounting intere...
Ferroptosis: process and function
Yang Xie, Wen‐Chi Hou, Xinxin Song et al. · 2016 · Cell Death and Differentiation · 3.6K citations
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker, Joseph M. Hendricks, Zhipeng Li et al. · 2019 · Nature · 3.3K citations
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll, Florêncio Porto Freitas, Ron Shah et al. · 2019 · Nature · 3.0K citations
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Matthew Dodson, Raúl Castro-Portuguez, Donna D. Zhang · 2019 · Redox Biology · 2.2K citations
The transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) is a key regulator of the cellular antioxidant response, controlling the expression of genes that counteract oxidative an...
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Wan Seok Yang, Katherine J. Kim, Michael M. Gaschler et al. · 2016 · Proceedings of the National Academy of Sciences · 2.2K citations
Significance Ferroptosis is a regulated form of cell death induced by loss of glutathione peroxidase 4 (GPX4) phospholipid peroxidase activity and lethal accumulation of reactive oxygen species. Sm...
Reading Guide
Foundational Papers
Start with Xie et al. (2016, 3597 citations) for core GPX4 process and Yang et al. (2016, 2166 citations) for lipoxygenase-driven peroxidation mechanisms essential to understanding regulation.
Recent Advances
Study Bersuker et al. (2019) and Doll et al. (2019) for FSP1 discoveries parallel to GPX4, plus Dodson et al. (2019) on NRF2 mitigation critical for cancer applications.
Core Methods
Key techniques include RSL3 GPX4 inhibition assays, CRISPR/Cas9 screens for regulators, lipid peroxidation measurement via BODIPY-C11, and NRF2 knockdown for pathway validation.
How PapersFlow Helps You Research GPX4 Regulation in Ferroptosis
Discover & Search
Research Agent uses searchPapers with query 'GPX4 regulation ferroptosis inhibitors RSL3' to retrieve 50+ papers including Bersuker et al. (2019) on FSP1 parallel pathway (3328 citations), then citationGraph maps co-citations with Tang et al. (2020) and exaSearch uncovers CRISPR screen datasets for novel regulators.
Analyze & Verify
Analysis Agent employs readPaperContent on Doll et al. (2019) to extract FSP1-GPX4 interaction data, verifies claims via verifyResponse (CoVe) against 10 related papers, and runPythonAnalysis on lipid peroxidation datasets with NumPy/pandas for statistical correlation (p<0.01). GRADE grading scores NRF2 pathway evidence as high-quality from Dodson et al. (2019).
Synthesize & Write
Synthesis Agent detects gaps in GPX4-NRF2 inhibitors via contradiction flagging across Sun et al. (2015) and Koppula et al. (2020), generates exportMermaid diagrams of regulatory networks. Writing Agent uses latexEditText for figure legends, latexSyncCitations for 20-paper bibliography, and latexCompile for prognosis review manuscript.
Use Cases
"Analyze lipid peroxidation rates in GPX4 knockout datasets from ferroptosis papers"
Research Agent → searchPapers 'GPX4 knockout ferroptosis datasets' → Analysis Agent → runPythonAnalysis (pandas load CSV, matplotlib plot peroxidation curves, t-test p-values) → researcher gets quantified stats showing 3-fold ROS increase (Yang et al., 2016).
"Draft LaTeX review on GPX4 inhibitors in cancer prognosis"
Synthesis Agent → gap detection on RSL3/FSP1 therapies → Writing Agent → latexEditText (add sections), latexSyncCitations (Tang 2020 et al.), latexCompile → researcher gets compiled PDF with 15 citations and ferroptosis pathway figure.
"Find code for CRISPR screens identifying GPX4 regulators"
Research Agent → searchPapers 'CRISPR GPX4 ferroptosis' → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (Bersuker et al. 2019 screen pipeline) → researcher gets Python scripts for hit validation and reproducibility.
Automated Workflows
Deep Research workflow scans 50+ papers on GPX4 regulation (e.g., Li et al., 2020; Xie et al., 2016), structures report with GRADE-scored sections on inhibitors and NRF2. DeepScan's 7-step chain verifies FSP1 claims (Doll et al., 2019) via CoVe checkpoints and Python stats. Theorizer generates hypotheses on GPX4 PTMs from citationGraph of 3,600+ ferroptosis papers.
Frequently Asked Questions
What defines GPX4 regulation in ferroptosis?
GPX4 reduces lipid hydroperoxides using glutathione; its inhibition by RSL3 triggers ferroptosis, modulated by FSP1 and NRF2 (Tang et al., 2020; Bersuker et al., 2019).
What methods study GPX4 regulation?
CRISPR screens identify regulators, RSL3 assays measure activity, and lipidomics quantify peroxidation; parallel FSP1 is assessed via CoQ oxidoreductase assays (Yang et al., 2016; Doll et al., 2019).
What are key papers on GPX4 regulation?
Bersuker et al. (2019, Nature, 3328 citations) on FSP1 parallel to GPX4; Doll et al. (2019, Nature, 2994 citations) on glutathione-independent suppression; Dodson et al. (2019) on NRF2-GPX4 axis.
What open problems exist?
Therapeutic windows for GPX4 inhibitors in cancer, context-specific PTMs, and FSP1/GPX4 interplay in prognosis lack resolution (Koppula et al., 2020; Sun et al., 2015).
Research Ferroptosis and cancer prognosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching GPX4 Regulation in Ferroptosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Ferroptosis and cancer prognosis Research Guide